
Zioper S 1000mg/500mg Injection
Marketer
Ziotic Life Sciences
Salt Composition
Cefoperazone (1000mg) + Sulbactam (500mg)
Overview Zioper S 1000mg/500mg Injection
Combiflox 1000mg/500mg Injection, a dual-action antibiotic, combats various bacterial infections by inhibiting microbial proliferation and spread. Administration must be strictly under a physician's guidance; adhere to the prescribed schedule and complete the entire course, regardless of symptom improvement. Premature cessation can compromise its effectiveness. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical attention. Seek immediate help for allergic reactions (rash, itching, swelling, dyspnea). Inform your doctor about all current medications, especially if pregnant or breastfeeding. Alcohol should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if experiencing drowsiness or dizziness. Adequate rest, nutrition, and hydration are crucial for optimal recovery. Your doctor may order tests to monitor treatment response.
Primary Ingredients of Zioper S 1000mg/500mg Injection
No text provided. Please provide the text you want me to rephrase.
Uses of Zioper S 1000mg/500mg Injection
Combating Bacterial Infections
Major Benefits of Zioper S 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Zioper S 1000mg/500mg Injection:
- Decreased white blood cell count (neutrophils)
- Decreased white blood cell count (lymphocytes)
- Decreased hemoglobin
- Decreased hematocrit level
- Low blood platelets
- Coagulation disorder
- Increased white blood cell count (eosinophils)
- Diarrhea
- Nausea
- Increased alanine aminotransferase
- Increased aspartate aminotransferase
- Increased alkaline phosphatase level in blood
- Vomiting
- Increased bilirubin in the blood
How to use Zioper S 1000mg/500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is not permitted.
How Zioper S 1000mg/500mg Injection works:
Zioper S 1000mg/500mg Injection combines Cefoperazone, a broad-spectrum antibiotic, with Sulbactam, a beta-lactamase inhibitor. Cefoperazone disrupts bacterial cell wall synthesis, hindering bacterial survival. Sulbactam's role is to counteract bacterial resistance mechanisms, thereby bolstering Cefoperazone's antibacterial effectiveness.
SAFETY ADVICE
AlcoholUNSAFE
Ingestion of alcohol during treatment with Zioper S 1000mg/500mg Injection can lead to adverse effects including facial flushing, tachycardia, queasiness, dehydration, pectoral pain, and hypotension (a disulfiram-like reaction).
PregnancySAFE IF PRESCRIBED
The injectable medication Zioper S (1000mg/500mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; however, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Zioper S (1000mg/500mg) is considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer to breast milk, posing no apparent risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Zioper S 1000mg/500mg Injection on driving ability is unknown. Refrain from operating a vehicle if you exhibit symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Zioper S 1000mg/500mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Zioper S 1000mg/500mg Injection to individuals with hepatic impairment. Physician consultation is recommended.
What if you forget to take Zioper S 1000mg/500mg Injection :
Omitting a scheduled dose of Zioper S 1000mg/500mg Injection warrants immediate physician consultation.
Facts to Know About Zioper S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
